I’ve been reading a bit of angst regarding covid trials, and announcements related to these trials. Admittedly I’m an engineer so a bit of a numpty at the best of times, but just trying to understand what I’m missing:
1) MSB as a company has had a fixed plan over a number of years for commercialisation of a number of products;
2) that plan hasn’t changed with the recent world events as far as I’m aware
3) (from an investors POV) covid-19 treatments are a bonus (and haven’t been priced in)
4) if 3 doesn’t eventuate, 1 ticks along as planned
I didn’t buy/hold msb hoping for a covid cure, but a bonus is a bonus. If, as a company they see value in diverting resources from the original plan In the short term to target this, ill trust their judgement that they view this as a value accretive move.
Provided this doesn’t alter the original plan at 1), why get worked up about not receiving warm and fuzzy’s about the add-on?
disclaimer: I hope msb and/or others are able to solve the covid dilemma, references to ‘bonus/add-on’ are purely from an unemotional investment pov
- Forums
- ASX - By Stock
- MSB
- Here's the latest (*******)
Here's the latest (*******), page-52
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 43856 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 66000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 43856 | 1.105 |
10 | 148573 | 1.100 |
3 | 95461 | 1.095 |
6 | 150805 | 1.090 |
4 | 77833 | 1.085 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 66000 | 1 |
1.115 | 89808 | 3 |
1.120 | 510896 | 9 |
1.125 | 100845 | 7 |
1.130 | 142733 | 8 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |